首页> 外文期刊>Translational psychiatry. >Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
【24h】

Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers

机译:内在功能连通性可预测抗抑郁药的缓解:一项随机对照试验,用于确定临床上可应用的影像生物标志物

获取原文
           

摘要

Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN functional connectivity as a general and differential biomarker for predicting treatment outcomes in a large, unmedicated adult sample with MDD. Seventy-five MDD outpatients completed fMRI scans before and 8 weeks after randomization to escitalopram, sertraline, or venlafaxine-XR. A whole-brain voxel-wise t -test identified profiles of pretreatment intrinsic functional connectivity that distinguished patients who were subsequently classified as remitters or non-remitters at follow-up. Connectivity was seeded in the PCC, an important node of the DMN. We further characterized differences between remitters, non-remitters, and 31 healthy controls and characterized changes pretreatment to posttreatment. Remitters were distinguished from non-remitters by relatively intact connectivity between the PCC and ACC/mPFC, not distinguishable from healthy controls, while non-remitters showed relative hypo-connectivity. In validation analyses, we demonstrate that PCC–ACC/mPFC connectivity predicts remission status with >80% cross-validated accuracy. In analyses testing whether intrinsic connectivity differentially relates to outcomes for a specific type of antidepressant, interaction models did not survive the corrected threshold. Our findings demonstrate that the overall capacity to remit on commonly used antidepressants may depend on intact organization of intrinsic functional connectivity between PCC and ACC/mPFC prior to treatment. The findings highlight the potential utility of functional scans for advancing a more precise approach to tailoring antidepressant treatment choices.
机译:默认模式网络(DMN)功能障碍(特别是在前扣带回皮质(ACC)和内侧前额叶皮质(mPFC)内)已与严重抑郁症(MDD)相关;然而,其对治疗结果的贡献尚未明确。在这里,我们测试了DMN功能性连接作为一般和差异生物标记物的作用,以预测大型未药物治疗的MDD成人样本的治疗结果。 75名MDD门诊患者在随机分配至依他普仑,舍曲林或文拉法辛XR之前和之后8周完成了fMRI扫描。一项全脑体素t检验确定了治疗前内在功能连通性的特征,从而区分了患者,这些患者随后在随访中被分为缓解者或非缓解者。连接性植入了PCC中,后者是DMN的重要节点。我们进一步表征了缓解者,非缓解者和31名健康对照之间的差异,并描述了治疗前至治疗后的变化。通过在PCC和ACC / mPFC之间的相对完整的连接(不同于正常控件),可以将重发器与非重发器区分开来,而非重发器则表现出相对低连通性。在验证分析中,我们证明PCC–ACC / mPFC连接性可以以> 80%的交叉验证准确性预测缓解状态。在分析测试内在连通性是否与特定类型的抗抑郁药的疗效差异相关的分析中,相互作用模型无法幸免于校正后的阈值。我们的研究结果表明,缓解常用抗抑郁药的总体能力可能取决于治疗前PCC与ACC / mPFC之间固有的功能连通性的完整组织。研究结果突显了功能扫描在推进更精确的抗抑郁治疗选择方法方面的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号